AIG
INFI

American International Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

American International Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,459
Closed -$50K – 3340
2022
Q1 		$50K Sell
43,459
-3,059
-7% -$3.66K ﹤0.01% 2843
2021
Q4 		$105K Sell
46,518
-1,392
-3% -$3.49K ﹤0.01% 2693
2021
Q3 		$164K Sell
47,910
-1,138
-2% -$3.51K ﹤0.01% 2548
2021
Q2 		$147 Buy
+49,048
New +$155K ﹤0.01% 2702
2017
Q2 		– Sell
-30,248
Closed -$98K – 3135
2017
Q1 		$98K Buy
30,248
+1,999
+7% +$4.92K ﹤0.01% 2607
2016
Q4 		$38K Sell
28,249
-74
-0.3% -$97 ﹤0.01% 2910
2016
Q3 		$44.2K Buy
28,323
+43
+0.2% +$66 ﹤0.01% 2922
2016
Q2 		$37.6K Sell
28,280
-443
-2% -$2.07K ﹤0.01% 3002
2016
Q1 		$151K Hold
28,723
– – ﹤0.01% 3044
2015
Q4 		$225K Sell
28,723
-50
-0.2% -$430 ﹤0.01% 2730
2015
Q3 		$243K Buy
28,773
+34
+0.1% +$314 ﹤0.01% 2639
2015
Q2 		$315K Sell
28,739
-1,784
-6% -$22.9K ﹤0.01% 2598
2015
Q1 		$427K Hold
30,523
– – ﹤0.01% 2289
2014
Q4 		$516K Sell
30,523
-1,207
-4% -$17.6K ﹤0.01% 2112
2014
Q3 		$426K Sell
31,730
-24
-0.1% -$286 ﹤0.01% 2283
2014
Q2 		$405K Sell
31,754
-802
-2% -$8.35K ﹤0.01% 2358
2014
Q1 		$387K Buy
32,556
+782
+2% +$10.5K ﹤0.01% 2278
2013
Q4 		$439K Sell
31,774
-319
-1% -$4.5K ﹤0.01% 2127
2013
Q3 		$560K Buy
32,093
+11,551
+56% +$221K ﹤0.01% 1875
2013
Q2 		$334K Buy
+20,542
New +$636K ﹤0.01% 2151

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

American International Group's INFI Position: Q2 2022 in Review

American International Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 43,459 shares — an estimated $50K sold.

American International Group first reported a position in INFI in Q2 2013 and held it in 20 quarters. The position peaked at $560K in Q3 2013. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

  • American International Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 43,459 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $50K.
  • American International Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • American International Group's Infinity Pharmaceuticals, Inc. position peaked at $560K in Q3 2013.
  • 77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.